View graph of relations
  1. 2019
  2. Published
    Koch, A., Jeschke, J., Van Criekinge, W., van Engeland, M., & De Meyer, T. (2019). MEXPRESS update 2019. Nucleic Acids Research, 47(W1), W561-W565. https://doi.org/10.1093/nar/gkz445
  3. Published
  4. Published
    van Lanschot, M. C. J., Carvalho, B., Rausch, C., Snaebjornsson, P., van Engeland, M., Kuipers, E. J., ... Meijer, G. A. (2019). Molecular profiling of longitudinally observed small colorectal polyps: A cohort study. EBioMedicine, 39, 292-300. https://doi.org/10.1016/j.ebiom.2018.12.009
  5. 2018
  6. Published
  7. Published
  8. Published
  9. Published
  10. Published
  11. Published
  12. 2017
  13. Published
  14. Published
    Bosch, L. J. W., Trooskens, G., Snaebjornsson, P., Coupe, V. M. H., Mongera, S., Haan, J. C., ... Meijer, G. A. (2017). Decoy receptor 1 (DCR1) promoter hypermethylation and response to irinotecan in metastatic colorectal cancer. Oncotarget, 8(38), 63140-63154. https://doi.org/10.18632/oncotarget.18702
  15. Published
  16. Published
  17. Published
  18. Published
  19. Published
  20. Published
    Ussi, A. E., Rebolj, M., Thorat, M. A., Bietrix, F., Fauvel, A-C., Hajduch, M., ... Meijer, G. (2017). Assessing opportunities for coordinated R&D in early cancer detection and management in Europe. International Journal of Cancer, 140(7), 1700-1701. https://doi.org/10.1002/ijc.30564
  21. Published
  22. Published
  23. Published
  24. 2016
  25. Published
  26. Published
  27. Published
  28. Published
  29. 2015
  30. Published
  31. Published
    Gao, L., van den Hurk, K., Nsengimana, J., Laye, J. P., van den Oord, J. J., Beck, S., ... van Doorn, R. (2015). Prognostic Significance of Promoter Hypermethylation and Diminished Gene Expression of SYNPO2 in Melanoma. Journal of Investigative Dermatology, 135(9), 2328-2331. https://doi.org/10.1038/jid.2015.163
  32. Published
  33. Published
  34. Published
  35. Published
  36. Published
  37. Published
  38. 2014
  39. Published
  40. Published
    Juo, Y. Y., Johnston, F. M., Zhang, D. Y., Juo, H. H., Wang, H., Pappou, E. P., ... Ahuja, N. (2014). Prognostic value of CpG island methylator phenotype among colorectal cancer patients: a systematic review and meta-analysis. Annals of Oncology, 25(12), 2314-2327. https://doi.org/10.1093/annonc/mdu149
  41. Published
    Gao, L., van den Hurk, K., Moerkerk, P. T. M., Goeman, J. J., Beck, S., Gruis, N. A., ... van Doorn, R. (2014). Promoter CpG Island Hypermethylation in Dysplastic Nevus and Melanoma: CLDN11 as an Epigenetic Biomarker for Malignancy. Journal of Investigative Dermatology, 134(12), 2957-2966. https://doi.org/10.1038/jid.2014.270
  42. Published
  43. Published
  44. Published
  45. Published
  46. Published
  47. Published
  48. Published
  49. Published
  50. 2013
  51. Published
  52. Published
  53. Published
    Hughes, L. A. E., Melotte, V., de Schrijver, J., de Maat, M., Smit, V. T. H. B. M., Bovee, J. V. M. G., ... van Engeland, M. (2013). The CpG Island Methylator Phenotype: What's in a Name? Cancer Research, 73(19), 5858-5868. https://doi.org/10.1158/0008-5472.CAN-12-4306
  54. Published
  55. Published
  56. Published
  57. Published
Previous 1 2 3 Next